NADH is the reduced form. NAD⁺ (nicotinamide adenine dinucleotide) is the oxidized form, and when it picks up two electrons and a hydrogen ion, it becomes NADH. That single distinction drives an enormous amount of what happens inside your cells, from extracting energy out of food to protecting DNA from damage. The chemistry is simple at its core, but the biology that depends on it turns out to be remarkably far-reaching.
What “Reduced” and “Oxidized” Actually Mean Here
In everyday language, “reduced” sounds like something got smaller. In chemistry, it means the opposite: a molecule gained electrons. NAD⁺ carries a positive charge because it is missing electrons. When enzymes strip electrons from nutrients like glucose or fatty acids, NAD⁺ accepts two of those electrons along with a hydrogen ion, becoming NADH. That loading event is the reduction. Going the other direction, when NADH hands those electrons off to something else, it gets oxidized back to NAD⁺.
The interconversion between these two forms can happen through a one-step transfer of a hydride ion (essentially a hydrogen atom carrying an extra electron) or, in some chemical contexts, through a more stepwise electron-proton-electron sequence.1PubMed. Transient species in the stepwise interconversion of NADH and NAD+ In living cells, the hydride transfer is the dominant route. The important thing to remember is that NAD⁺ is the empty taxi waiting for passengers, and NADH is the loaded taxi carrying high-energy electrons to their destination.
Where NADH Gets Made
Your cells produce NADH in several places, but the biggest contributors are the metabolic pathways that break down food. When glucose is split apart during glycolysis in the cell’s cytoplasm, NAD⁺ picks up electrons and becomes NADH. For every molecule of glucose that goes through glycolysis, two molecules of NADH are generated.2PLOS ONE. Modelling the impact of changes in the extracellular environment on the cytosolic free NAD+/NADH ratio during cell culture More NADH is produced inside the mitochondria when the breakdown products of glucose, fats, and amino acids feed into the citric acid cycle. Fat breakdown alone generates a substantial amount of NADH through a process called beta-oxidation.
All of this NADH is essentially a temporary energy warehouse. The electrons it carries still hold a lot of chemical energy, and the cell needs to cash that energy in. That happens at the inner membrane of the mitochondria.
Where NADH Gets Spent
The payoff for making NADH comes at the electron transport chain, a series of protein complexes embedded in the inner mitochondrial membrane. The first stop is Complex I, formally called NADH:ubiquinone oxidoreductase. Complex I strips the electrons from NADH, oxidizing it back to NAD⁺, and uses the energy released to pump protons across the membrane.3PubMed. Mitochondrial complex I That proton gradient is what ultimately drives the production of ATP, the molecule your cells use as direct fuel for almost everything they do.
This is why the NAD⁺/NADH cycle matters so much for energy. NAD⁺ collects electrons from food, becomes NADH, delivers those electrons to the mitochondria, and gets recycled back to NAD⁺ to do it all again. Without a steady supply of NAD⁺ to accept electrons, the whole system stalls.
The Problem of Membrane Barriers
One quirk of this system is that NADH made in the cytoplasm cannot simply walk into the mitochondria. The inner mitochondrial membrane is impermeable to both NADH and NAD⁺.4PubMed. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools So cells use indirect shuttle systems to get those electrons across. The malate-aspartate shuttle is the most common one: cytoplasmic NADH passes its electrons to a small molecule called oxaloacetate, converting it to malate. Malate crosses into the mitochondria, where the electrons are handed back to NAD⁺, regenerating NADH on the mitochondrial side. The glycerol phosphate shuttle is another route, though it deposits electrons at a slightly lower energy level.
In the heart, research has shown that this shuttle capacity can become a bottleneck during high workloads. When the heart is pumping hard, the transfer of reducing equivalents from the cytoplasm into the mitochondria via the malate-aspartate shuttle may not keep pace with demand.5PubMed. Limited transfer of cytosolic NADH into mitochondria at high cardiac workload This is a reminder that the cell’s plumbing for moving electrons around has real physical limits.
A similar shuttle challenge exists in peroxisomes, small organelles involved in fat processing. Recent work using gene-editing tools in human cells revealed that peroxisomes maintain their own NAD⁺/NADH balance through internal lactate dehydrogenase and malate dehydrogenase enzymes, keeping their redox state in sync with the cytoplasm.6PubMed Central. Human peroxisomal NAD(+)/NADH homeostasis is regulated by two independent NAD(H) shuttle systems
Why the Ratio Between NAD⁺ and NADH Matters
Your cells do not just care about how much total NAD they have. They care about the balance between the oxidized (NAD⁺) and reduced (NADH) forms. A healthy cell keeps this ratio tilted heavily toward NAD⁺ in the cytoplasm, meaning most of the NAD pool is in its “empty” electron-accepting form. Inside mitochondria, the ratio shifts toward more NADH, reflecting the constant electron loading happening there.
When that ratio shifts in the wrong direction, things go wrong. An excess of NADH relative to NAD⁺ creates what researchers call reductive stress: too many electrons with nowhere to go. Paradoxically, this reductive stress eventually triggers oxidative stress, because electrons start leaking out of the transport chain and reacting with oxygen to form damaging reactive oxygen species.7PubMed Central. Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications This cascade of reductive-then-oxidative stress damages proteins, lipids, and DNA, and has been linked to complications of diabetes and other metabolic conditions.
In the heart specifically, a lowered NAD⁺/NADH ratio under diabetic conditions worsens cardiac function. Mouse studies have shown that when this redox imbalance is combined with genetic vulnerability, it exacerbates both the structural and functional deterioration of the heart muscle.8PubMed Central. NAD(+) Redox Imbalance in the Heart Exacerbates Diabetic Cardiomyopathy The broader pattern is clear: the NAD⁺/NADH ratio is not just a bookkeeping number. It is a signal that the cell uses to coordinate metabolism, and when it goes off, the downstream consequences are serious.9PubMed Central. Role of NAD+ in regulating cellular and metabolic signaling pathways
NAD⁺ Does More Than Carry Electrons
If carrying electrons were the whole story, NAD⁺ would already be one of the most important molecules in biology. But it has a second life entirely separate from redox chemistry. Several families of enzymes use NAD⁺ as a raw material, consuming it rather than just borrowing it. Sirtuins, which regulate gene expression, DNA repair, and inflammation, break NAD⁺ apart to do their work. Poly-ADP-ribose polymerases (PARPs), which patch damaged DNA, also consume NAD⁺. And CD38, an enzyme found on the surface of immune cells, chews through NAD⁺ at a remarkable rate.10PubMed Central. NAD+ metabolism and its roles in cellular processes during ageing
This means your cells face a constant tug-of-war: they need NAD⁺ for energy metabolism (the redox cycling between NAD⁺ and NADH) and they also need NAD⁺ as fuel for these signaling and repair enzymes. When NAD⁺ levels drop, both functions suffer. The sirtuins cannot do their protective work without NAD⁺, and PARP-driven DNA repair slows down.11PubMed Central. NAD+ and sirtuins in aging and disease
How Cells Recycle and Replenish NAD⁺
Because NAD⁺ gets consumed (not just cycled), cells need to constantly rebuild their supply. The primary route for this is the salvage pathway. When sirtuins, PARPs, or CD38 break NAD⁺ apart, one of the byproducts is nicotinamide. An enzyme called NAMPT (nicotinamide phosphoribosyltransferase) grabs that nicotinamide and starts rebuilding it back into NAD⁺. This salvage pathway is especially important in tissues with high energy demands, like skeletal muscle.12PubMed Central. Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function
The salvage pathway is not just about keeping the lights on. When cells face mild oxidative stress, the NAMPT-driven recovery of NAD⁺ determines whether damaged cells die in an orderly way (apoptosis) or a messy, inflammatory way (necrosis). Blocking NAMPT in stressed cells prevents NAD⁺ recovery and shifts the outcome from clean apoptosis to destructive necrosis.13Cell Death Discovery. NAMPT-dependent NAD+ salvage is crucial for the decision between apoptotic and necrotic cell death under oxidative stress So the ability to recycle NAD⁺ is not a minor housekeeping task. It affects whether injured tissue heals cleanly or triggers inflammation.
NAD⁺ Decline With Aging
One of the more striking findings in aging research over the past decade is that NAD⁺ levels fall as organisms get older. The culprit, at least in part, appears to be CD38. Studies in mice have shown that CD38 expression and activity increase with age, and this ramp-up directly drives the decline in tissue NAD⁺ levels. The downstream effects include mitochondrial dysfunction mediated by reduced activity of SIRT3, a mitochondrial sirtuin that depends on NAD⁺.14PubMed Central. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism
The mechanism connecting aging to CD38 overactivity has become clearer in recent years. As animals age, senescent cells accumulate in metabolic tissues like fat and liver. These senescent cells secrete inflammatory signals that cause nearby macrophages to proliferate and ramp up their CD38 expression. Those CD38-loaded macrophages then consume NAD⁺ at an accelerated rate, dragging down the tissue’s overall NAD⁺ pool.15Nature Metabolism. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages It is an unfortunate feedback loop: aging creates senescent cells, senescent cells stoke inflammation, inflammation drives CD38, and CD38 depletes NAD⁺.
Boosting NAD⁺ Back Up
The age-related decline in NAD⁺ has sparked intense interest in finding ways to restore it. Two supplement precursors, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), have become the molecules of choice for both animal experiments and early human trials because they are orally bioavailable and feed directly into the salvage pathway.16Cell Metabolism. NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Enzymes and Metabolites Whether they consistently raise NAD⁺ levels enough to produce meaningful health benefits in humans remains an active and unsettled question, despite enthusiastic marketing around both.
A different strategy targets the consumption side rather than the supply side. If CD38 is a major driver of NAD⁺ depletion in aging, then blocking CD38 should preserve NAD⁺. A specific CD38 inhibitor called 78c has shown promise in mice: it reversed age-related NAD⁺ decline and improved glucose tolerance, muscle function, exercise capacity, and cardiac function.17PubMed Central. A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD(+) Decline A follow-up study in naturally aged mice found that 78c also extended both lifespan and healthspan.18PubMed Central. CD38 inhibitor 78c increases mice lifespan and healthspan in a model of chronological aging These are animal results and the usual caveats apply, but they illustrate why NAD⁺ biology has become one of the hotter areas in geroscience.
NADH Versus NADPH
A common point of confusion is the difference between NADH and NADPH. They look almost identical, differing only by a single phosphate group. But their jobs in the cell barely overlap. NADH is the cell’s main shuttle for delivering electrons to the energy-producing machinery in mitochondria. NADPH, on the other hand, is the primary electron donor for the cell’s antioxidant defenses and for biosynthetic reactions like building fatty acids and cholesterol. NADH powers catabolism (breaking things down for energy); NADPH powers anabolism (building things up) and detoxification.19PubMed. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences
Interestingly, both reduced forms can contribute to the production of reactive oxygen species, but through different routes. NADH feeds electrons into the mitochondrial chain where some leak to form superoxide, while NADPH fuels a dedicated enzyme family called NADPH oxidases that immune cells use to deliberately generate bursts of reactive oxygen to kill pathogens. So the “reduced” form of each coenzyme carries electrons, but the context and consequences of those electrons diverge sharply.
Measuring NAD⁺ and NADH in Practice
Researchers who study NAD biology need reliable ways to measure both forms. This is trickier than it sounds. NADH is chemically unstable and degrades quickly after a tissue sample is collected, so sample preparation has to be fast and cold. Traditional enzymatic cycling assays use the fluorescence of NADH (NAD⁺ does not fluoresce the same way) to quantify each form after selectively destroying the other with heat or acid.20PubMed. Assays for Determination of Cellular and Mitochondrial NAD(+) and NADH Content More recently, mass spectrometry methods using stable isotope-labeled NAD⁺ as an internal standard have pushed sensitivity higher while cutting analysis time to under ten minutes.21PubMed Central. A Simple, Fast, Sensitive LC-MS/MS Method to Quantify NAD(H) in Biological Samples: Plasma NAD(H) Measurement to Monitor Brain Pathophysiology
For research on how shifts in the NAD⁺/NADH ratio rewire metabolism, scientists can track glucose labeled with specific isotopes through the cell’s metabolic pathways, revealing where NADH is being produced and consumed.22PubMed Central. Protocols for analyzing metabolic derangements caused by increased NADH/NAD(+) ratio in cell lines and in mice These methods are mainly research tools right now, not something you would encounter in a clinical lab. But as interest in NAD⁺ supplementation grows, there is increasing discussion about whether NAD⁺ and NADH levels in blood could serve as biomarkers for metabolic health or aging.
NAD⁺ as an RNA Cap
One of the more unexpected recent discoveries in molecular biology is that NAD⁺ moonlights as a cap on RNA molecules. Normally, messenger RNA in eukaryotic cells carries a specialized chemical cap at its front end that protects it from degradation and helps it get translated into protein. Researchers found that NAD⁺ can replace this standard cap, attaching directly to the beginning of an RNA strand during transcription when the RNA polymerase grabs NAD⁺ instead of its usual starting nucleotide.23PubMed. Noncanonical RNA-capping: Discovery, mechanism, and physiological role debate
This happens in both bacteria and eukaryotes. In budding yeast, over 1,400 RNA species have been found with NAD caps, and they tend to be short fragments corresponding to the beginnings of messenger RNAs. The cell does not seem to want most of them: NAD-capped mRNAs are not translatable, and yeast have evolved at least three different enzymes dedicated to stripping off NAD caps and destroying these RNAs.24Nature Communications. Extensive 5′-surveillance guards against non-canonical NAD-caps of nuclear mRNAs in yeast One intriguing hypothesis is that the ratio of NAD⁺ to NADH in a cell could influence how much NAD-capping occurs, potentially linking the cell’s metabolic state to its gene expression. The idea that your cell’s energy balance might leave chemical fingerprints on its RNA is still being worked out, but it adds yet another layer to what NAD⁺ and NADH do beyond their textbook roles in energy metabolism.